Arcus Biosciences (RCUS) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$831.0 million.
- Arcus Biosciences' Enterprise Value rose 2369.15% to -$831.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$831.0 million, marking a year-over-year increase of 2369.15%. This contributed to the annual value of -$978.0 million for FY2024, which is 2885.38% down from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Enterprise Value is -$831.0 million, which was up 2369.15% from -$911.0 million recorded in Q2 2025.
- Arcus Biosciences' 5-year Enterprise Value high stood at -$499.0 million for Q4 2021, and its period low was -$1.2 billion during Q1 2022.
- Over the past 5 years, Arcus Biosciences' median Enterprise Value value was -$954.0 million (recorded in 2023), while the average stood at -$906.8 million.
- Examining YoY changes over the last 5 years, Arcus Biosciences' Enterprise Value showed a top increase of 3294.73% in 2021 and a maximum decrease of 42381.51% in 2021.
- Arcus Biosciences' Enterprise Value (Quarter) stood at -$499.0 million in 2021, then crashed by 102.2% to -$1.0 billion in 2022, then grew by 24.78% to -$759.0 million in 2023, then decreased by 28.85% to -$978.0 million in 2024, then increased by 15.03% to -$831.0 million in 2025.
- Its last three reported values are -$831.0 million in Q3 2025, -$911.0 million for Q2 2025, and -$997.0 million during Q1 2025.